These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Freytag SO, Khil M, Stricker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E, Kim JH. Cancer Res; 2002 Sep 01; 62(17):4968-76. PubMed ID: 12208748 [Abstract] [Full Text] [Related]
50. Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit. Yin L, Fu S, Wang X, Nanakorn T, Won J, Deisseroth A. Chin Med J (Engl); 2001 Sep 01; 114(9):972-5. PubMed ID: 11780394 [Abstract] [Full Text] [Related]
52. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE. Cancer Res; 1995 Nov 01; 55(21):4808-12. PubMed ID: 7585511 [Abstract] [Full Text] [Related]
54. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Kanai F, Lan KH, Shiratori Y, Tanaka T, Ohashi M, Okudaira T, Yoshida Y, Wakimoto H, Hamada H, Nakabayashi H, Tamaoki T, Omata M. Cancer Res; 1997 Feb 01; 57(3):461-5. PubMed ID: 9012474 [Abstract] [Full Text] [Related]
59. Regression of experimental liver tumor after distant intra-hepatic injection of cytosine deaminase-expressing tumor cells and 5-fluorocytosine treatment. Pierrefite-Carle V, Baque P, Gavelli A, Benchimol D, Bourgeon A, Milano G, Saint-Paul MC, Rossi B. Int J Mol Med; 2000 Mar 01; 5(3):275-8. PubMed ID: 10677568 [Abstract] [Full Text] [Related]